These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10532438)

  • 21. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ; Dempsey OJ; Aziz I
    Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
    Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
    Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients.
    Cloosterman SG; Bijl-Hofland ID; van Herwaarden CL; Akkermans RP; van Den Elshout FJ; Folgering HT; van Schayck CP
    Chest; 2001 May; 119(5):1306-15. PubMed ID: 11348933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
    Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM;
    Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes.
    Lindén C; Alm A
    Arch Ophthalmol; 1997 Jul; 115(7):857-61. PubMed ID: 9230825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P; Clark M; Thompson Coon J; Lewis S; Rushton L; Bennett J; Oborne J; Cooper S; Tattersfield AE
    BMJ; 1997 May; 314(7092):1441-6. PubMed ID: 9167559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
    Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
    Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
    Bhagat R; Kalra S; Swystun VA; Cockcroft DW
    Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
    Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG; Papapanos P; Tersis I; Houliara D; Stewart WC
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma.
    Drance SM; Crichton A; Mills RP
    Am J Ophthalmol; 1998 May; 125(5):585-92. PubMed ID: 9625541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.
    Stewart WC; Day DG; Stewart JA; Schuhr J; Latham KE
    Am J Ophthalmol; 2001 May; 131(5):631-5. PubMed ID: 11336939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.